EGFR and non-small cell lung carcinoma: In addition, EMT is closely associated with chemotherapeutic drug resistance, e.g., 5-FU resistance in CRC, sorafenib resistance in hepatocellular carcinoma, and anti-EGFR therapy resistance in non–small cell lung cancer (NSCLC) (20–23).